What is Cerebral?
Founded in 2020 and headquartered in San Francisco, Cerebral operates as a comprehensive mental health telemedicine platform. The company specializes in providing high-quality medication management, counseling, and therapy services for conditions such as anxiety, depression, and insomnia. By removing traditional barriers to entry, Cerebral has effectively democratized access to mental healthcare, allowing patients to receive professional support through a seamless, internet-enabled interface. Its market position is defined by a focus on patient-centric care, utilizing data-driven insights to optimize treatment outcomes while maintaining a scalable business model that addresses the global mental health crisis.
How much funding has Cerebral raised?
Cerebral has raised a total of $560.8M across 6 funding rounds:
Series A
$35M
Series B
$127M
Series C
$300M
Stock/Share Issuance
$25M
Other Financing Round
$25M
Stock/Share Issuance
$48.8M
Series A (2020): $35M with participation from Gaingels LLC, Oak HC/FT, Westcap Corp., Air Angels Inc, and Liquid 2 Ventures L.P
Series B (2021): $127M, investors not publicly disclosed
Series C (2021): $300M supported by Prysm Capital and SoftBank Group Corp
Other Financing Round (2025): $25M, investors not publicly disclosed
Stock/Share Issuance (2025): $25M, investors not publicly disclosed
Stock/Share Issuance (2026): $48.8M, investors not publicly disclosed
Key Investors in Cerebral
Prysm Capital
Prysm Capital is a flexible source of growth capital and partnership for disruptive teams, focusing on technology and consumer sectors.
SoftBank Group Corp
SoftBank Group Corp. is a global technology holding company driving innovation across telecommunications, internet services, artificial intelligence, and clean energy technologies.
Oak HC/FT
Oak HC/FT is the premier venture growth-equity fund investing in Healthcare Information & Services and Financial Services Technology, focused on driving industry transformation.
What's next for Cerebral?
With the recent capital deployment, Cerebral is well-positioned to accelerate its product development and expand its reach within the competitive telemedicine sector. The strategic focus will likely shift toward enhancing its clinical service offerings and deepening its integration with existing healthcare ecosystems. As the company matures, the emphasis will remain on maintaining high standards of care while navigating the regulatory environment inherent to digital health. Investors are closely monitoring Cerebral's ability to sustain its growth momentum, particularly as it seeks to refine its unit economics and solidify its role as a leader in the mental health technology space. The company's future success will depend on its ability to balance rapid scaling with the rigorous clinical requirements of the healthcare industry.
See full Cerebral company page
